Israel cấp phép thuốc Molnupiravir của Merck, cho phép tiêm liều 4

Bộ Y tế Israel ngày 2/1 thông báo đã cấp phép sử dụng thuốc điều trị COVID-19 do tập đoàn dược phẩm đa quốc gia Merck của Mỹ sản xuất, sau quyết định tương tự đối với thuốc Paxlovid của Pfizer.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh